Anna Sparshatt

938 total citations
16 papers, 581 citations indexed

About

Anna Sparshatt is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Anna Sparshatt has authored 16 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 3 papers in Clinical Psychology. Recurrent topics in Anna Sparshatt's work include Schizophrenia research and treatment (14 papers), Treatment of Major Depression (5 papers) and Electroconvulsive Therapy Studies (4 papers). Anna Sparshatt is often cited by papers focused on Schizophrenia research and treatment (14 papers), Treatment of Major Depression (5 papers) and Electroconvulsive Therapy Studies (4 papers). Anna Sparshatt collaborates with scholars based in United Kingdom, Qatar and United States. Anna Sparshatt's co-authors include David Taylor, Maxine X. Patel, Shitij Kapur, Olubanke Olofinjana, Sanskriti Varma, Delia Bishara, Victoria Cornelius, Olubanké Dzahini, Sarah Jones and Maria O’Hagan and has published in prestigious journals such as BMJ, The Journal of Clinical Psychiatry and Acta Psychiatrica Scandinavica.

In The Last Decade

Anna Sparshatt

16 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Sparshatt United Kingdom	13	405	150	82	77	71	16	581
Maosheng Fang China	15	523 1.3×	141 0.9×	68 0.8×	146 1.9×	104 1.5×	29	974
Sergio De Filippis Italy	17	500 1.2×	104 0.7×	63 0.8×	151 2.0×	46 0.6×	66	766
Philippe Bouhours France	11	329 0.8×	131 0.9×	88 1.1×	70 0.9×	37 0.5×	20	481
Luke Vano United Kingdom	5	545 1.3×	89 0.6×	84 1.0×	96 1.2×	122 1.7×	10	823
Thomas Walch Austria	14	406 1.0×	83 0.6×	37 0.5×	102 1.3×	77 1.1×	15	781
Ataru Inagaki Japan	11	386 1.0×	73 0.5×	45 0.5×	83 1.1×	48 0.7×	24	636
Silvia Paletta Italy	12	382 0.9×	128 0.9×	38 0.5×	112 1.5×	44 0.6×	29	673
Dennis Sweitzer United States	11	672 1.7×	196 1.3×	102 1.2×	142 1.8×	49 0.7×	13	833
Olubanke Olofinjana United Kingdom	7	195 0.5×	79 0.5×	41 0.5×	47 0.6×	56 0.8×	8	322
Stephen Kaplita United States	9	609 1.5×	268 1.8×	36 0.4×	94 1.2×	48 0.7×	18	961

Countries citing papers authored by Anna Sparshatt

Since Specialization

Citations

This map shows the geographic impact of Anna Sparshatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sparshatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sparshatt more than expected).

Fields of papers citing papers by Anna Sparshatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Sparshatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sparshatt. The network helps show where Anna Sparshatt may publish in the future.

Co-authorship network of co-authors of Anna Sparshatt

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Sparshatt. A scholar is included among the top collaborators of Anna Sparshatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Sparshatt. Anna Sparshatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Taylor, David, et al.. (2017). Aripiprazole long-acting injection – a mirror image study of its effects on hospitalisation at one year. Journal of Psychopharmacology. 31(12). 1564–1569. 14 indexed citations

Taylor, David, Anna Sparshatt, Maria O’Hagan, & Olubanké Dzahini. (2016). Paliperidone palmitate: factors predicting continuation with treatment at 2 years. European Neuropsychopharmacology. 26(12). 2011–2017. 15 indexed citations

Taylor, David, Anna Sparshatt, Maria O’Hagan, & Olubanké Dzahini. (2016). Effect of paliperidone palmitate on hospitalisation in a naturalistic cohort – a four-year mirror image study. European Psychiatry. 37. 43–48. 32 indexed citations

Taylor, David, Anna Sparshatt, Sanskriti Varma, & Olubanke Olofinjana. (2014). Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies. BMJ. 348(mar19 5). g1888–g1888. 127 indexed citations

Bishara, Delia, Olubanke Olofinjana, Anna Sparshatt, et al.. (2013). Olanzapine. Journal of Clinical Psychopharmacology. 33(3). 329–335. 47 indexed citations

Sparshatt, Anna, R. Hamish McAllister‐Williams, David S. Baldwin, et al.. (2012). A naturalistic evaluation and audit database of agomelatine: clinical outcome at 12 weeks. Acta Psychiatrica Scandinavica. 128(3). 203–211. 8 indexed citations

Connolly, Anne, David Taylor, Anna Sparshatt, & Victoria Cornelius. (2011). Antipsychotic prescribing in Black and White hospitalised patients. Journal of Psychopharmacology. 25(5). 704–709. 12 indexed citations

Sparshatt, Anna, David Taylor, Maxine X. Patel, & Shitij Kapur. (2011). Relationship Between Daily Dose, Plasma Concentrations, Dopamine Receptor Occupancy, and Clinical Response to Quetiapine. The Journal of Clinical Psychiatry. 72(8). 1108–1123. 36 indexed citations

Sparshatt, Anna, David Taylor, Maxine X. Patel, & Shitij Kapur. (2010). A Systematic Review of Aripiprazole—Dose, Plasma Concentration, Receptor Occupancy, and Response. The Journal of Clinical Psychiatry. 71(11). 1447–1456. 74 indexed citations

10.

Taylor, David, et al.. (2009). Risperidone long‐acting injection: a 6‐year mirror‐image study of healthcare resource use. Acta Psychiatrica Scandinavica. 120(2). 97–101. 28 indexed citations

11.

Sparshatt, Anna, David Taylor, Maxine X. Patel, & Shitij Kapur. (2009). Amisulpride – dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring. Acta Psychiatrica Scandinavica. 120(6). 416–428. 58 indexed citations

12.

Sparshatt, Anna, Sarah Jones, & David Taylor. (2008). Quetiapine. CNS Drugs. 22(1). 49–68. 34 indexed citations

13.

Sparshatt, Anna, Eromona Whiskey, & David Taylor. (2008). Valproate as prophylaxis for clozapine-induced seizures: survey of practice. Psychiatric Bulletin. 32(7). 262–265. 5 indexed citations

14.

Taylor, David, et al.. (2008). Risperidone Long-Acting Injection. The Journal of Clinical Psychiatry. 70(2). 196–200. 44 indexed citations

15.

Taylor, David, et al.. (2007). A prospective 6‐month analysis of the naturalistic use of aripiprazole – factors predicting favourable outcome. Acta Psychiatrica Scandinavica. 116(6). 461–466. 9 indexed citations

16.

Atkinson, James, et al.. (2007). Outcome Following Clozapine Discontinuation. The Journal of Clinical Psychiatry. 68(7). 1027–1030. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact